Abstract
Bladder and kidney cancer together account for about 5% of cancers worldwide, and represent the 9th and 14th most common cancers in terms of absolute numbers, respectively. Our knowledge of these two cancers, however, indicates that they have strikingly different etiology. A number of important occupational, lifestyle and genetic factors have been implicated in bladder carcinogenesis, which have greatly increased our understanding of this disease. In some instances, identification of these factors has contributed to the prevention or reduction of exposure to bladder carcinogens. Conversely, the etiology of kidney cancer is less well elucidated, which limits the possibilities for reducing its incidence by this approach. It is likely that much remains to be uncovered about the causes of these two cancers, and these advances will increase our appreciation of the biology of these cancers and perhaps lead to further possibilities for their prevention. In this article, we evaluate the epidemiology of bladder and kidney cancer and also discuss potential priorities for future research.
Key Points
-
Populations with a high incidence of bladder cancer include the Mediterranean countries of Europe and Egypt, whereas populations with a high incidence of kidney cancer include central Europe and the black population of the US
-
Improved survival for both bladder and kidney cancer is associated with a young age at diagnosis and also differs between countries; geographical differences are particularly apparent for kidney cancer
-
Tobacco smoking is the most important risk factor for bladder cancer; occupational exposure to aromatic amines and infection with Schistosoma hematobium are also important recognized risk factors
-
Tobacco smoking is also a recognized risk factor for kidney cancer, as are obesity and hypertension
-
Genetic variants of GSTM1 and NAT2 influence bladder cancer risk, and NAT2 variants interact with smoking status to exacerbate bladder cancer risk
-
Apart from rare, high-risk genetic variants, susceptibility genes for kidney cancer are yet to be discovered
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Eble JN et al. (Eds; 2004) World Health Organization classification of tumours—pathology and genetics of tumours of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer
Parkin DM et al. (Eds; 2005) Cancer Incidence in Five Continents, Vols I–VIII (IARC CancerBase No. 7). Lyon: International Agency for Research on Cancer
el-Mawla NG et al. (2001) Bladder cancer in Africa: update. Semin Oncol 28: 174–178
Ochicha O et al. (2003) Bladder cancer in Kano—a histopathological review. West Afr J Med 22: 202–204
Sow M et al. (2006) Epidemiological and histological features of urogenital tumours in Cameroon [French]. Prog Urol 16: 36–39
Groeneveld AE et al. (1996) Bladder cancer in various population groups in the greater Durban area of KwaZulu-Natal, South Africa. Br J Urol 78: 205–208
Kogevinas M and Trichopoulos D (2002) Urinary bladder cancer. In Textbook on Cancer Epidemiology, 446–466 (Eds Adami HO et al.) Oxford University Press
National Cancer Database (online 30 October 2006) [http://www.facs.org/cancer/ncdb/] (accessed 21 February 2007)
Kiemeney LA et al. (1994) Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975–1989. Eur J Cancer 30 (Pt A): 1134–1137
Hock LM et al. (2002) Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of Surveillance, Epidemiology and End Results program data. J Urol 167: 57–60
Roazzi P et al. (2003) Electronic availability of EUROCARE-3 data: a tool for further analysis. Ann Oncol 14 (Suppl 5): v150–v155
Smart CR (1990) Bladder cancer survival statistics. J Occup Med 32: 926–928
Timberg G et al. (1997) Bladder cancer in Estonia, 1968–1992: incidence, mortality, prevalence and survival. Scand J Urol Nephrol 31: 337–342
Jemal A et al. (2004) Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 101: 3–27
Chow WH et al. (1999) Rising incidence of renal cell cancer in the United States. JAMA 281: 1628–1631
Damhuis RA and Kirkels WJ (1998) Improvement in survival of patients with cancer of the kidney in Europe. Eur J Cancer 34: 2232–2235
Stenbeck M et al. (1995) Cancer survival in Sweden during three decades, 1961–1991. Acta Oncol 34: 881–891
Tjonneland A et al. (1993) Survival of Danish cancer patients 1943–1987. Urinary tract. APMIS Suppl 33: 137–148
Ferlay J et al. (Eds; 2004) Globocan 2002—Cancer Incidence, Mortality and Prevalence Worldwide (IARC CancerBase No. 5, version 2.0). Lyon: International Agency for Research on Cancer
Parkin DM et al. (Eds; 2002) Cancer Incidence in Five Continents, Volume VIII (IARC Scientific Publication No. 155). Lyon: International Agency for Research on Cancer
Parkin DM et al. (Eds; 1992) Cancer Incidence in Five Continents, Volume VI (IARC Scientific Publication No. 120). Lyon: International Agency for Research on Cancer
Zheng T et al. (1996) Time trend and age–period–cohort effect on incidence of bladder cancer in Connecticut, 1935–1992. Int J Cancer 68: 172–176
Mellemgaard A et al. (1993) Trends in the incidence of cancer of the kidney, pelvis, ureter and bladder in Denmark, 1943–1988. Scand J Urol Nephrol 27: 327–332
Brennan P et al. (2000) Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case–control studies. Int J Cancer 86: 289–294
Brennan P et al. (2001) The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control 12: 411–417
IARC Monographs on the Evaluation of Carcinogenesis risks to Humans, Volume 83 (2004) Tobacco smoke and involuntary smoking. Lyon: International Agency for Research on Cancer
Fortuny J et al. (1999) Tobacco, occupation and non-transitional-cell carcinoma of the bladder: an international case–control study. Int J Cancer 80: 44–46
Siemiatycki J et al. (2004) Listing occupational carcinogens. Environ Health Perspect 112: 1447–1459
Riboli E and Norat T (2003) Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 78 (Suppl 3): 559S–569S
Pelucchi C et al. (2006) Mechanisms of Disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 3: 327–340
Villanueva CM et al. (2006) Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer 118: 2040–2047
AICR World Cancer Research Fund (1997) Food, nutrition and the prevention of cancer: a global perspective. Washington DC: American Institute for Cancer Research
Lin J et al. (2006) Bladder cancer risk as modified by family history and smoking. Cancer 107: 705–711
Garcia-Closas M et al. (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366: 649–659
IARC Monographs on the Evaluation of Carcinogenesis risks to Humans, Supplement 7 (1987) Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. Lyon: International Agency for Research on Cancer
IARC Monographs of the Evaluation of Carcinogenesis risks to Humans, Volume 61 (1994) Schistosomes, Liver Flukes and Helicobacter pylori. Lyon: International Agency for Research on Cancer
Bedwani R et al. (1998) Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 77: 1186–1189
CDC Laboratory Identification of Parasites of Public Health Concern [http://www.dpd.cdc.gov/DPDx/HTML/Schistosomiasis.htm] (accessed 23 February 2007)
Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118: 3030–3044
Hunt JD et al. (2005) Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer 114: 101–108
McLaughlin JK et al. (1995) International renal-cell cancer study. I. Tobacco use. Int J Cancer 60: 194–198
Yuan JM et al. (1998) Tobacco use in relation to renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 7: 429–433
IARC Handbooks of Cancer Prevention, Volume 6 (2002) Weight control and physical activity. Lyon: International Agency for Research on Cancer
Bergstrom A et al. (2001) Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91: 421–430
Bergstrom A et al. (2001) Obesity and renal cell cancer—a quantitative review. Br J Cancer 85: 984–990
McLaughlin JK et al. (1995) International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer 63: 216–221
Yuan JM et al. (1998) Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer 77: 1508–1513
Chow WH et al. (2000) Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 343: 1305–1311
Flaherty KT et al. (2005) A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control 16: 1099–1106
Grossman E et al. (2002) Is there an association between hypertension and cancer mortality? Am J Med 112: 479–486
Lindgren AM et al. (2005) Cancer pattern among hypertensive patients in North Karelia, Finland. J Hum Hypertens 19: 373–379
Benichou J et al. (1998) Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol 148: 424–430
Lindblad P et al. (1999) The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 42: 107–112
Wideroff L et al. (1997) Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89: 1360–1365
Lindblad P and Adami HO (2002) Kidney cancer. In Textbook on Cancer Epidemiology, 467–485 (Eds Adami HO et al.) New York: Oxford University Press
IARC Handbooks of Cancer Prevention, Volume 8 (2003) Fruit and vegetables. Lyon: International Agency for Research on Cancer
Weikert S et al. (2006) Fruits and vegetables and renal cell carcinoma: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 118: 3133–3139
Wolk A et al. (1996) International renal cell cancer study. VII. Role of diet. Int J Cancer 65: 67–73
Sali D and Boffetta P (2000) Kidney cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies. Cancer Causes Control 11: 37–47
Brauch H et al. (1999) Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma. J Natl Cancer Inst 91: 854–861
Amundadottir LT et al. (2004) Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 1: 229–236
Risch N (2001) The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 10: 733–741
Lichtenstein P et al. (2000) Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78–85
Richard S et al. (2004) von Hippel–Lindau disease. Lancet 363: 1231–1234
Batuman V (2006) Fifty years of Balkan endemic nephropathy: daunting questions, elusive answers. Kidney Int 69: 644–646
Acknowledgements
G Scélo worked on this manuscript during her tenure of a Special Training Award from the International Agency for Research on Cancer.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Scélo, G., Brennan, P. The epidemiology of bladder and kidney cancer. Nat Rev Urol 4, 205–217 (2007). https://doi.org/10.1038/ncpuro0760
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0760
This article is cited by
-
Roles of enhancer RNAs in sex hormone-dependent cancers
Journal of Cancer Research and Clinical Oncology (2022)
-
Incidence of bladder cancer in Benghazi, Libya over the past three decades
Scientific Reports (2018)
-
Precision medicine from the renal cancer genome
Nature Reviews Nephrology (2016)
-
Preclinical and clinical studies on cytokine-induced killer cells for the treatment of renal cell carcinoma
Archives of Pharmacal Research (2014)
-
Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986–2007
Cancer Causes & Control (2014)